Article
Genomic analysis across 53 canine cancer types reveals novel mutations and high clinical actionability potential.
Veterinary and comparative oncology - 1 Mar 2024
Sakthikumar Sharadha, Warrier Manisha, Whitley Derick, Facista Salvatore, Adkins Jonathan, Aman Sara, Tsinajinnie Darwin, Duran Natalie, Siravegna Giulia, Ahmed Zeeshan, Day Kenneth, Jenkins Brooklyn, Patel Nidhi, Ryden Kirk, Nadai Joe, Banovich Kathryn, Powers Barbara, Edwards Jeffrey, Steinberg Jennifer, Fielder Susan, Wong Shukmei, Byron Sara A, Izatt Tyler, Zismann Victoria, Boateng Martin, Zhu Zhanyang, Chuang Han-Yu, Trent Jeffrey M, Haworth David, Chon Esther, Hendricks William, Wang Guannan
Abstract excerpt
A genomic understanding of the oncogenic processes and individual variability of human cancer has steadily fueled improvement in patient outcomes over the past 20 years. Mutations within tumour tissues are routinely assessed through clinical genomic diagnostic assays by academic and commercial laboratories to facilitate diagnosis, prognosis and effective treatment stratification. The application of genomics has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
